Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma is a research paper published in Journal of Clinical Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 49 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH HHS
Grant: P51 OD011132
NIGMS NIH HHS
Grant: T32 GM142617
NIAMS NIH HHS
Grant: R01 AR077926
NCI NIH HHS
Grant: R01 CA238471
NCI NIH HHS
Grant: P30 CA138292
NCI NIH HHS
Grant: R35 CA197603
NCI NIH HHS
Grant: U54 CA260563
NIAID NIH HHS
Grant: HHSN272201400004C
NIGMS NIH HHS
Grant: T32 GM008169
NIAID NIH HHS
Grant: U19 AI090023
National Institutes of Health
Grant: 3P51OD011132-64S2
Renovation to expand and enhance NHP housing for HIV/AIDS research at the Emory NPRC
National Institutes of Health
Grant: 1U54CA260563-01
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
National Institutes of Health
Grant: 1U19AI090023-01
Systems Biological Analysis of Innate and Adaptive Responses to Vaccination
National Institutes of Health
Grant: 1R35CA197603-01A1
Harnessing Host Response to Prevent Myeloma
National Institutes of Health
Grant: 5P30CA138292-11
Winship Cancer Institute Cancer Center Support Grant
FWCI
4.42
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals